ArticleBreast cancer (Dove Medical Press)2025

Real-World Analysis of the Efficacy and Adverse Events of T-DM1 in Chinese Patients With HER2-Positive Breast Cancer.

Huayan Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.